SOL.MI - SOL S.p.A.

Milan - Milan Delayed Price. Currency in EUR

SOL S.p.A.

Via Borgazzi, 27
Monza 20900
Italy
39 03 923961
http://www.solgroup.com

SectorBasic Materials
IndustryChemicals
Full Time Employees3,958

Key Executives

NameTitlePayExercisedYear Born
Mr. Aldo Fumagalli RomarioChairman, Co-CEO & MD577.46kN/A1958
Mr. Marco AnnoniVice Chairman, Co-CEO & MD577.96kN/AN/A
Mr. Giulio Fumagalli RomarioDirector of Legal & Corp. Bus. and Director573.6kN/AN/A
Mr. Giovanni AnnoniDirector of Information Systems & Director578.24kN/AN/A
Marco FilippiCFO & Mang.N/AN/AN/A
Amounts are as of December 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

SOL S.p.A. engages in the applied research, production, and distribution of industrial gases, pure and medicinal gases, and in door-to-door medical care and related medical equipment in Italy and internationally. It offers technical and medical gases, including oxygen, nitrogen, argon, hydrogen, carbon dioxide, acetylene, nitrous oxide, gas mixtures, high purity gases, food gases, and gaseous helium, as well as synthetic and compressed air; gases and gas mixtures for respiratory and therapeutic, and diagnostic and instrumental use; and special gases and gas mixtures. The company also provides services, apparatus, and products for home oxygen therapy, home mechanical ventilation, home artificial feeding, and home treatment of bed sores; home treatment services for nocturnal apnoea syndrome; and integrated homecare services. In addition, it produces hydroelectric power; and engages in the exploration and identification, design, construction, and running of hydroelectric power stations connected to the national high tension distribution network. Further, the company designs, constructs, and manages bio banks, cell factories, and centers for processing and conserving cells and tissues; offers pre-and post-natal diagnostic services; and produces and sells diagnostic systems and services. Additionally, it is involved in the GMP production of monoclonal antibodies and recombinant proteins; and scientific, pre-clinical, and clinical research of biological pharmaceuticals, as well as the provision of transport and biological sample conservation services for third parties. SOL S.p.A. products are used in the chemical, electronics, iron and steel, engineering, and foodstuff industries, as well as in environmental protection and research and health sectors. The company was founded in 1927 and is headquartered in Monza, Italy. SOL S.p.A. is a subsidiary of Gas and Technologies World BV.

Corporate Governance

SOL S.p.A.’s ISS Governance QualityScore as of July 29, 2019 is 9. The pillar scores are Audit: 5; Board: 9; Shareholder Rights: 1; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.